Call for Papers: Brain-lung crosstalk

BMC Pulmonary Medicine warmly welcomes submissions to its new article Collection on crosstalk between the brain and lungs.
Call for Papers: Brain-lung crosstalk
Like

Share this post

Choose a social network to share with, or copy the URL to share elsewhere

This is a representation of how your post may appear on social media. The actual post will vary between social networks

Brain-injured patients are more likely to develop respiratory disorders and vice versa because the brain and the lungs communicate through complex bi-directional pathways which are not yet fully understood. There is a need for increased knowledge of the neuroanatomical, humoral, immune and metabolic pathways that the brain and lung use to talk to each other. Therefore, BMC Pulmonary Medicine has launched a call for papers to bring together research on the mechanisms underlying crosstalk between the brain and the lungs as well as studies investigating the epidemiology, pathophysiology and management of lung disorders in brain-injured patients to create an open access resource for all those interested in the field.

To learn more about the Collection’s scope, read the opening editorial written by the Guest Editors, which discusses recent advances, knowledge gaps and challenges faced by researchers investigating crosstalk between the brain and the lungs.

Meet the Guest Editors

Denise Battaglini: Consultant in Neuro and General Intensive Care, Policlinico San Martino Hospital, Italy

Denise Battaglini is Consultant in Intensive Care at San Martino Policlinico Hospital, Genoa, Italy. Dr Battaglini is attending a PhD in Translational Medicine at the University of Barcelona, Spain. She attended two research fellowhips in pneumonia and respiratory physiotherapy at the University of Barcelona, Spain, and in neurological and pulmonary critical care at the Federal University of Rio de Janeiro, Brazil. She is involved in several research projects regarding critical care management of patients with pulmonary and neurological diseases, neurological complications of COVID-19 ARDS, ventilator-associated pneumonia, respiratory physiotherapy, and lung-and-gut microbiota in neurocritically ill patients.

Chiara Robba: Consultant in Neuro and General Intensive Care, Policlinico San Martino Hospital, Italy

Chiara Robba is a Consultant in Neuro and GeneralIntensive Care at Policlinico San Martino, Genova. She worked for many years at Addenbrookes Hospital, in Cambridge and she got a PhD in Neuroscience under the supervision of Prof Marek Czosnyka. She is currently Chair-Elect of the Neuro Intensive Care section of the ESICM. Her research interests are mainly on Neuromonitoring, autoregulation and mechanical ventilation.

James A. Town: Assistant Professor, Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Director, Medical Intensive Care Unit, Harborview Medical Center, University of Washington, Seattle, Washington.

Dr Town is an Assistant Professor of Pulmonary and Critical Care Medicine at the University of Washington. He works in the Intensive Care Units at Harborview Medical Center where he is also the Director of the Medical ICU. His clinical and academic interests are in quality improvement, post-cardiac arrest care, bedside ultrasound and medical education.

Sarah Wahlster: Section Head, Neurocritical Care in the Department of Neurology at the University of Washington, Seattle, Washington

Dr Wahlster obtained her medical degree at the Ruprecht-Karls Universität Heidelberg, followed by a post-doc in Epigenetics of Neurodegenerative Disease at Harvard Medical School. She completed neurology residency and neurocritical care fellowship at MassGeneral/Brigham in Boston, and is now the section head of Neurocritical Care in the Department of Neurology at Harborview Medical Center. Her academic interests include Mechanical Ventilation in Acute Brain Injury, Extubation and Tracheostomy Decisions in the NeuroICU, Long-Term Outcomes of Patients and their Families After Severe Acute Brain Injury, Neuroprognostication after Cardiac Arrest, Neurological Care in Resource-Limited Settings, and Medical Education.

Submission Guidelines

This Collection welcomes submission of original Research Articles. Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal. Articles for this Collection should be submitted via our submission system, Snapp. During the submission process you will be asked whether you are submitting to a Collection, please select “Brain-lung crosstalk” from the dropdown menu.

Articles will undergo the journal’s standard peer-review process and are subject to all of the journal’s standard policies. Articles will be added to the Collection as they are published.

The Guest Editors have no competing interests with the submissions which they handle through the peer review process. The peer review of any submissions for which the Guest Editors have competing interests is handled by another Editorial Board Member who has no competing interests.

Submission Status: Open   |   Submission Deadline: 10 January 2024

Please sign in or register for FREE

If you are a registered user on Research Communities by Springer Nature, please sign in

Follow the Topic

Clinical Medicine
Life Sciences > Health Sciences > Clinical Medicine
Respiratory Tract Diseases
Life Sciences > Health Sciences > Clinical Medicine > Diseases > Respiratory Tract Diseases
Health Care
Life Sciences > Health Sciences > Health Care

Related Collections

With collections, you can get published faster and increase your visibility.

Aging and lung disease

BMC Pulmonary Medicine calls for submissions to our Collection on Aging and lung disease. The aging process is associated with physiological changes in the respiratory system, leading to an increased susceptibility to lung diseases such as chronic obstructive pulmonary disease (COPD), interstitial lung disease, and lung cancer. Additionally, age-related alterations in the immune system, including inflammaging and cellular senescence, contribute to the pathogenesis of lung diseases. Understanding the complex interplay between aging and lung disease is crucial for developing effective strategies for prevention, diagnosis, and management. Continued advancement of our collective understanding in this area is essential for addressing the growing burden of lung diseases in aging populations. Recent advances have elucidated the molecular mechanisms underlying inflammaging and senescence in the context of lung disease, paving the way for the development of novel therapeutic approaches targeting these processes. Furthermore, research has highlighted the impact of aging on the susceptibility to respiratory infections and the development of lung cancer, emphasizing the need for tailored interventions for older adults. This Collection supports and amplifies research related to SDG 3: Good Health and Well-being and SDG 10: Reduced Inequalities. Topics might include but are not limited to: • Inflammaging and its impact on lung health • Senolytics and their potential in treating age-related lung diseases • Age-related changes in the lung microenvironment • Respiratory infections in aging populations • Lung cancer in the context of aging

Publishing Model: Open Access

Deadline: Jul 08, 2025

Extracellular vesicles in pulmonary disease and medicine

BMC Pulmonary Medicine is calling for submissions to our upcoming Collection on Extracellular vesicles in pulmonary disease and medicine. Pulmonary diseases pose a significant health burden globally. Understanding the intricate involvement of extracellular vesicles in pulmonary pathophysiology is crucial for advancing our knowledge and developing novel therapeutic approaches. This Collection strives to explore extracellular vesicles in pulmonary health, including their roles as potential biomarkers, mediators of intercellular communication, and therapeutic targets. We welcome original research that contributes to our understanding of extracellular vesicles in pulmonary disease, including but not limited to: • Characterization of extracellular vesicles in pulmonary diseases • Diagnostic and prognostic potential of extracellular vesicles • Therapeutic applications of extracellular vesicles in pulmonary disease • The interplay between extracellular vesicles and pulmonary disease risk factors • Mechanisms of extracellular vesicle-mediated cell-to-cell communication in pulmonary health and disease • Extracellular vesicles as mediators of inflammation and oxidative stress in the pulmonary system • Novel technologies and methodologies for studying extracellular vesicles in pulmonary research • Translational potential and challenges in harnessing extracellular vesicles for pulmonary therapeutics This Collection aligns with the United Nations' Sustainable Development Goal 3: Good Health and Well-Being. By focusing on the pivotal role of extracellular vesicles in pulmonary disorders, we aim to shed light on their multifaceted aspects and provide valuable insights into potential strategies for diagnosis, treatment, and overall management.

Publishing Model: Open Access

Deadline: Mar 26, 2025